A Radiopharma Facility Choose-Your-Own Adventure
You’re leading a new radiopharmaceutical manufacturing facility project targeting Lu-177, with plans to add a second isotope later. Three early decisions will shape your budget, schedule, and stress level. For each question, choose the option you’d take and expand it to see the implications.
WHERE DO YOU START?
You’ve kicked off design on a new radiopharma facility. Milestones are aggressive. The team wants “drawings yesterday,” and future isotopes are already in the conversation. You have time to focus on one thing this week.
What do you tackle first? (Expand to see the implications of each choice.)
With the 211/212 path and future isotopes on the table, zoning, cleanroom strategy, and pressure cascades are now grounded in clear rules instead of guesswork. You don’t have as many drawings yet, but the ones that follow are far less likely to be torn apart later.
Floor plans and cleanroom diagrams come together quickly, but they’re built on assumptions about classification, air change rates, and material flows. The team feels momentum, yet several “finished” rooms may need to be reworked once regulators and licensing catch up.
Early estimates look better, but key choices on systems and finishes are being made before license, classification, and future isotopes are fully defined. Some of the savings you’re locking in now may disappear later when designs are updated to actually meet regulatory and process requirements.
HOW FAR DO YOU PLAN BEYOND LU-177?
You’ve aligned on license and classification for Lu-177. Your design-build partner is asking how much to plan for future isotopes and additional capacity.
What do you do? (Expand to see the implications of each choice.)
You keep initial cost and complexity lower, which is great if the priority is getting this first facility online quickly. The tradeoff is future flexibility; adding isotopes or capacity later will likely mean more invasive construction and downtime.
You accept a moderate cost bump now for upsized utilities, extra penetrations, and reserved space. In return, you get a clearer path to expand later without rebuilding core infrastructure.
You commit the most capital and design effort up front to create a very flexible backbone. That can pay off if growth comes quickly, but it ties up budget in capacity you may not need right away.
WHAT DOES YOUR DAY 1 LOOK LIKE?
You’ve set your license strategy and decided how far beyond Lu-177 to plan. Now you’re aligning with your design-build team on schedule and what “done” means.
What do you do? (Expand to see the implications of each choice.)
You show a longer overall schedule on paper, but you’re being honest about how long validation really takes. Dates you share with leadership are more likely to stick, and the end of the project tends to feel planned instead of chaotic.
You present the most aggressive timeline and the earliest possible revenue start. If anything slips in construction or validation, there’s very little buffer—small issues can quickly turn into missed launch dates and last-minute pressure.
You reach initial production sooner and start using the facility while the rest of the scope wraps up. In return, you take on more complexity—two phases to plan, two sets of expectations to manage, and often extra coordination cost.
HOW DO YOU APPROACH MULTIPLE SITES?
You’re no longer thinking about just one facility. You’re looking at several locations across the country that will need radiopharmaceutical production over the next few years. How do you approach the network?
What do you do? (Expand to see the implications of each choice.)
You invest once in a robust design and repeat it, which can shorten design timelines and make operations, training, and maintenance more consistent across sites. The tradeoff is flexibility. Tight standardization can be harder to fit into certain shells, jurisdictions, or business plans without compromises.
You define a strong baseline for layout and systems, then allow targeted changes for each building, code environment, or market. This adds some design effort at each site, but balances speed and consistency with enough flexibility to avoid forcing the same solution everywhere.
Each site is optimized for its specific shell, regulatory context, and commercial plan, which can be valuable in complex or constrained locations. In return, you take on more design time, more coordination, and a more varied network to operate and maintain, with fewer shared patterns from project to project.
Congratulations! You’ve taken the first steps to building your radiopharma network.
Along the way, you made four calls that every team has to wrestle with:
There isn’t one “perfect” path. Each choice trades cost, speed, flexibility, and risk in different ways. The teams that land in the best spot are the ones that name those tradeoffs early, align around them, and work with a partner who can design and build to that plan.
Planning to build or expand a radiopharma facility? Let’s talk about what’s right for your program.